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University, Boston, MassachusettsABSTRACT A computational model of blood coagulation is presented with particular emphasis on the regulatory effects of
blood flow, spatial distribution of tissue factor (TF), and the importance of the thrombomodulin-activated protein C inhibitory
pathway. We define an effective prothrombotic zone that extends well beyond the dimensions of injury. The size of this zone
is dependent on the concentrations of all reactive species, the dimensions of TF expression, the densities of surface molecules,
and the characteristics of the flow field. In the case of tandem sites of TF, the relationship between the magnitude of the effective
prothrombotic zone and the interval distance between TF sites dictate the net response of the system. Multiple TF sites, which
individually failed to activate the coagulation pathway, are shown to interact in an additive manner to yield a prothrombotic
system. Furthermore, activation of the thrombomodulin-activated protein C pathway in the regions between sites of TF down-
regulate the thrombin response at subsequent TF sites. The implications of prothrombotic effects, which extend downstream
beyond the discrete site of injury to interact with subsequent lesions are critical given the systemic nature of atherosclerotic
disease.INTRODUCTIONBlood coagulation is a highly dynamic, nonlinear reaction
network that is characterized by the activation and amplifi-
cation of circulating zymogens, several surface-associated
enzyme complexes, and positive and negative feedback
loops. Exposure of subendothelial tissue factor (TF) to the
bloodstream and subsequent formation of the TF/VIIa
complex leads to activation of factors (F) IX and X. Gener-
ation of FXa by either intrinsic (IXa/VIIIa) or extrinsic
(TF/VIIa) tenase leads to assembly of prothrombinase
(Xa/Va), which cleaves prothrombin (FII) to thrombin
(FIIa). Amplification of the cascade is achieved through
positive feedback of thrombin to activate FV and FVIII
(1,2). Regulators of thrombin generation include the
thrombin- and thrombomodulin (TM)-dependent protein C
pathway, FXa-dependent TF pathway inhibitor (TFPI),
and the multisubstrate serine protease inhibitor, anti-
thrombin III (ATIII) (1–4). In addition, blood flow serves
as a critical regulator of thrombosis by removing activated
enzymes from the site of reactivity (5). The temporal and
spatial dynamics of coagulation under flow are complex,
and mathematical modeling provides a means for the
systematic study of individual components and their roles
in promoting or regulating clot formation.Rationale for the model approach
Mathematical models of blood coagulation vary widely and
range from well-mixed solution-phase models to those
which incorporate elements such as diffusion of solutesSubmitted May 1, 2011, and accepted for publication May 19, 2011.
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0006-3495/11/07/0276/11 $2.00and vascular surface reactivity. In general, fluid-phase
models of the kinetics of coagulation are computationally
and experimentally less complex and, as such, are able to
incorporate a number of species and reactions. Empirical
data are often available for regression analysis and model
validation. However, the essential role of blood flow in
promoting the delivery of substrates to the vessel wall and
in regulating the thrombin response by removing activated
clotting factors is well recognized. The major limitation of
the existing pseudo-one-compartment models of coagula-
tion under flow (6,7), in which the vascular space is divided
into a bulk and a boundary volume, is the assumption of
spatially homogenous, or well-mixed, plasma compart-
ments. This assumption breaks down as the dimensions of
the boundary volume increase, as would occur, for example,
at low shear rates and for large reaction areas, due to the
potential for substrate depletion and product accumulation
at the surface or at upstream sites. In contrast, although
models incorporating spatial effects have recently been
reported (8–10), most describe only reaction and diffusion
and do not include convective effects. Recently, Leiderman
and Fogelson (11) reported a spatiotemporal model of coag-
ulation and platelet deposition over a short segment of
exposed subendothelium under flow. The authors explored
the hypothesis set forth by their previous works, which
proposed that platelet deposition over an injury site physi-
cally inhibited further TF-mediated activation of coagula-
tion. Furthermore, they suggest that for small injuries
(~10 mm in length), physical factors, i.e., fluid flow and
platelet deposition, and not biochemical anticoagulants,
may be the dominant regulators of thrombin generation.
However, their model did not include endothelial reactions,
including those of the TM-protein C pathway. Of note,doi: 10.1016/j.bpj.2011.05.056
Thrombin Generation in a Flow Field 277models that have incorporated the TM-protein C pathway
include a multiscale model by Xu et al. (12), in which the
role of factor VII in venous thrombogenesis was examined,
and earlier work by Fogelson et al. (13).
The finite-element method (FEM) does not require the
assumption of spatial homogeneity and permits the defini-
tion of a flow model that accounts for distinct sites of TF
and TM surface expression. Uniquely, spatial parameters
quantifying the localization or propagation of thrombin
formation, in both vertical and longitudinal directions,
may be defined.METHODS
Model description
Here, we describe a spatially heterogeneous FEMmodel of thrombin gener-
ation under defined flow conditions that describes the events that occur after
TF exposure at a discrete upstream site, as well as related mechanisms that
regulate thrombin generation, including those mediated by an intact endo-
thelium, represented as a TM-containing surface (Fig. 1 A). The primary
analysis was performed assuming a 10-mm inert entrance region, 2-mm
TF region, and a 34-mm TM region. The length of the TF region is similar
in dimension to that of a ruptured coronary plaque or the interface between
a vascular graft and host vessel at an anastomotic site (14). The nondimen-
sionalized model is independent of absolute chamber height.
In contrast to previous models of surface-induced coagulation, mass
transfer approximations are not used to describe transport of reactants to
the surface. Transport of soluble species is described by two-dimensional,
unsteady, convection-diffusion-reaction equations. Surface-bound species
are defined by time derivatives. All concentrations are initially set to
zero, and surface TF and TM are both initially free of bound cofactors.
Soluble species enter the flow field at mean physiologic values (Table S1
in the Supporting Material). Inlet FVIIa is assumed to be 1% of inlet
FVII (15). Hemophilias A and B were defined at 5% of the normal plasmaconcentration of FVIII and FIX, respectively. The lower reactive boundary
is divided into localized upstream TF and downstream TM regions. The
upper boundary is inert. Reaction kinetics define flux boundary conditions
on the upper and lower surfaces. Convective flux removes soluble species at
the outlet.
The model incorporates fluid phase and surface-associated reactions of
the extrinsic, intrinsic, and common pathways, as well as three inhibitory
pathways—ATIII, TFPI, and the protein C (PC) pathway. A description
and schematic can be found in Fig. S1. Table S2 summarizes all model
reactions and kinetic parameters and distinguishes between surface-bound
reactions and those that occur both in the fluid phase and at the blood-
vessel-wall interface.Model assumptions
Reactive surface
The model defines discrete regions of TF or TM expression, but otherwise
does not discriminate between subendothelium, resting endothelium, acti-
vated endothelium, or platelet membrane surfaces. Total TF and TM
surface expression is assumed constant over all time points. TF only binds
FVIIa and not FVII. Activation of FVII is assumed to occur in the fluid
phase only. The model assumes that phospholipid conditions promote
surface-associated enzyme complex assembly, i.e., membrane-binding sites
are in excess. All complexes not involving TF or TM are allowed to
assemble along the entire length of the reactive surface. Surface com-
plexes, such as prothrombinase, are assumed to be generated through a
bimolecular reaction between two solution-phase species spatially local-
ized at y ¼ 0. The assembly of these complexes is assumed to occur in
one step. Lateral diffusion along or within the membrane surface is consid-
ered negligible.
Kinetic parameters
Serine protease activation involves one or more cleavage events and is thus
irreversible. All reactions are assumed to followMichaelis-Menten kinetics.
The capacity of enzymes in the absence of respective cofactors to convert
primary substrates is considered negligible. For example, conversion ofFIGURE 1 Formulation of a spatially heteroge-
neous model of surface-induced thrombin genera-
tion in a flow field. Soluble species enter the flow
field at constant inlet concentrations. Diffusion
transports coagulation factors to the lower reactive
surface, where reaction kinetics define flux
boundary conditions. The upper boundary is inert.
Convective flux removes soluble species at the
outlet. (A) Initial geometric conditions include
a 10-mm entrance region, a 2-mm TF region, and
a 34-mm TM region. FSTG is defined as the inte-
gral of the downstream thrombin surface con-
centration over the 60-min simulation time,
normalized by time and length. (B) In the tandem
model, overall chamber length is fixed at 3 cm.
Three TF regions of length 200 mm each are spaced
at fixed intervals (10 mm in this illustration) with
intervening TM regions. rFSTG is defined as the
integral of the thrombin surface concentration
over the intervening TM surface over the 60-min
simulation time, normalized by time and length.
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278 Jordan and Chaikofprothrombin to thrombin by Xa/Va is 105-fold faster than by FXa alone
(16). Only the former reaction is considered. Kinetic parameters were
obtained from the experimental literature of isolated reaction systems
(Table S2 and Table S3), with preference given to studies deemed most rele-
vant with respect to concentrations within the physiologic range, presence
of applicable cofactors, and method of measurement. In cases where only
equilibrium binding constants, Kd, were reported, kd was calculated
(kd ¼ Kd  ka) with ka set to the diffusional limit, 108 M1 s1. Association
reactions are reversible except where noted.
Inhibitory reactions
Thrombin activates PC when bound to TM, and the thrombin-TM complex
is considered the only source for PC activation. FXa-mediated activation of
PC has not been confirmed and therefore is not considered (17,18). Throm-
bin’s ability to participate in procoagulant reactions is eliminated once
bound to TM. Inactivation of FVa and FVIIIa by activated protein C
(APC) is irreversible. The cofactor activity of protein S (PS) was indirectly
accounted for through the choice of kinetic parameters for APC-mediated
inactivation of FVa and FVIIIa, which were measured in the presence of
physiologic concentrations of PS (19). Inactivation of FVa and inactivation
of FVIIIa are assumed to occur at equal rates (20). FIXa and FXa protect
their respective cofactors FVIIIa and FVa from inactivation by APC
when bound (19,21). ATIII irreversibly removes FIXa, FXa, and thrombin
by a bimolecular binding reaction. Acceleration of ATIII activity by surface
glycosaminoglycans is not included. TFPI acts in a two-step process by
binding reversibly to FXa in the fluid phase, followed by reversible TFPI/
Xa association with surface bound TF/VIIa (4). Only plasma TFPI is
considered. Inducible TFPI from platelets and endothelial cells is not
included.
Flow regime
Simulations were conducted assuming steady, nonpulsatile, fully developed
parabolic flow. In select instances, analyses were performed for a range of
shear rates between 100 and 1500 s1. However, in most cases, compari-
sons were conducted at simulated arterial (500 s1) and venous (50 s1)
flow regimes.Model implementation
Governing equations
Model reactions and corresponding rate constants are summarized in Table
S2. The full set of partial differential equations and boundary conditions can
also be found in the Supporting Material. Equations, bulk parameters, and
initial values were nondimensionalized and geometrically scaled to
moderate the range of parameter values and reduce mesh size. All fluid-
phase species are defined by a conservation equation containing a rate of
accumulation, a convective term, a diffusive term, and a fluid-phase reac-
tion rate. Concentration is a function of time and two-dimensional space.
Surface-phase reaction rates appear as flux conditions in the boundary
conditions.
Computer implementation
The FEM model was implemented in COMSOL Multiphysics 3.4
(COMSOL, Burlington, MA) on a 64-bit Windows workstation. The auto-
matically generated mesh contained ~2100 triangular elements, with finer
resolution over the reactive boundaries and intersection points. Increasing
mesh resolution to 3500 and 7200 triangular elements yielded results within
99% of the presented results. Soluble species were defined by a convection-
diffusion application mode. Surface-bound enzymatic complex formation
was specified by a weak form (boundary) application mode. Time-depen-
dent simulations were solved using a direct parallel solver. Simulations
were run for 60 min. Postprocessing was performed in both COMSOL
and MATLAB (The MathWorks, Natick, MA).Biophysical Journal 101(2) 276–286System parameters describing surface-induced
thrombin generation over spatially discrete
regions of TF and TM
Simulations provide transient concentration profiles in two dimensions
for each of the 21 computationally defined species (16 fluid-phase and 5
surface-bound). System parameters were defined to describe the behavior
of the initiating TF region and to quantify the effectiveness of the TM-
expressing downstream region in modulating the thrombin response. Peak
thrombin concentration and flow-simulated thrombin generation (FSTG)
were chosen to evaluate the thresholdlike response of the model system.
Peak thrombin concentration was defined as the maximum level of
thrombin attained at any point in the computational space. FSTG is defined
as the integral of downstream thrombin surface concentration over the
60-min simulation time, normalized by time and length, or, in other words,
the average downstream surface thrombin concentration. FSTG acts as
a global variable incorporating both spatial and temporal information.
The downstream average was chosen as an indication of the effectiveness
of downstream TM in limiting thrombin generation near to the upstream
TF region. One hour was chosen as the default simulation time to ensure
that all phases of coagulation, e.g., initiation and propagation, were
included in the analysis for all runs. In other words, the simulation time
exceeded the time course of the least thrombogenic simulation conditions.
Finally, unique to our spatial model, an effective prothrombotic zone (EPZ)
defined the extent to which thrombin propagated away from the site of
surface-bound TF, in both axial and radial directions, by delineating a region
wherein at any point within the space the thrombin concentration was
within 95% of the peak level at steady state. The choice of a relative
concentration represents a penetration distance that is the geometric area
affected by the perturbation caused by the exposed TF segment regardless
of the absolute magnitude of the effect. Thus, the parameter is an indicator
of the decay in the rate of thrombin generation. The dimensions of this EPZ,
the effective prothrombotic length (EPL) and the effective prothrombotic
height (EPH), were determined as the x-intercept and maximum y-coordi-
nate of the delineating contour line, respectively. It should be noted that
the EPL includes the entire length of the site of expressed TF.Modeling tandem lesions
We explored the behavior of systems containing multiple spatially distinct
sites of surface-bound TF. The reactive boundary is divided into three sites
of TF with intervening regions that present TM (Fig. 1 B). TF length and
density were 200 mm and 9 fmol/cm2, respectively. These conditions
were previously found to be just below the activation threshold when adja-
cent to transport-limited levels of TM (1000 fmol/cm2). TF lengths shorter
than the previous section were chosen to achieve a wider range of effective
prothrombotic lengths that would fit within a manageable total chamber
length. The total length of the system of interest was 3 cm unless otherwise
noted. The TF interval was defined as the distance between the upstream
ends of two adjacent sites of TF. Regional FSTG (rFSTG) was derived
from a consideration of the total thrombin generated over the downstream
interval regions during the course of a 60-min simulation. An rFSTG
value >10 nM was similarly defined as a criterion for characterizing
a segment as exceeding an activation-threshold limit. Model equations
governing flow and reaction kinetics remained unchanged. Similar mesh
and solver algorithms were employed.RESULTS
The system exhibits threshold responses to TF,
TM, and wall shear rate
Characteristically, low levels of thrombin are produced
during the initiation phase of coagulation. During this phase,
Thrombin Generation in a Flow Field 279inhibitors may dampen the thrombin response and prevent
amplification and full activation of the coagulation cascade;
this is considered a subthreshold thrombin response. When
the capacity of these inhibitors is overwhelmed by the
magnitude of the thrombogenic stimulus, thrombin levels
cross an activation threshold and rapid amplification of
thrombin generation occurs. This threshold effect may be
defined with respect to a number of variables (e.g., blood
flow, fluid- and surface-phase levels of procoagulant factors
and inhibitors, and kinetic variables), and thus, an infinite
set of threshold-defining permutations exist beyond which
thrombin is produced in an almost instantaneous manner.
Using our computational model, we conducted parametric
studies that would not have been experimentally efficient.
Peak thrombin concentration reflected the all-or-none
behavior of thrombin generation and easily differentiated
between subthreshold and fully activated systems. Likewise,
by setting a cutoff of 10 nM for FSTG, notably the concen-
tration reported to induce platelet activation (22), systems
were reliably categorized as lying either below or above
an activation threshold.
We examined the relationship between the length of the
TF region and thrombin production while maintaining TF
and TM surface densities at or near transport-limited levels
of 1 and 1000 fmol/cm2, respectively. At a shear rate of
500 s1, peak thrombin concentration and FSTG fell below
the activation threshold of 10 nM if the TF site wasA C
DB
FIGURE 2 Threshold response of thrombin to TF site length, TF surface densi
Peak thrombin concentration and FSTG as functions of TF length at a wall she
(C and D) Peak thrombin concentration and FSTG as functions of TF surface den
1000 fmol/cm2. (E and F) Peak thrombin concentration and FSTG as function
thrombin concentration and FSTG as functions of wall shear rate. TF and T
1000 fmol/cm2, respectively. Simulations were run to 60 min. Activation of clo<1.6 mm in length (Fig. 2, A and B). With further length-
ening of the TF region, peak thrombin concentration and
FSTG increased sharply and peak thrombin approached
1200 nM, consistent with full activation of the coagulation
cascade.
A similar threshold effect was observed in relation to
TF surface concentration. At venous (50 s1) and arterial
(500 s1) shear rates, TM (1000 fmol/cm2) inhibited
thrombin production at TF concentrations below 0.03 and
0.8 fmol/cm2, respectively (Fig. 2, C and D; venous data
not shown). The TF surface concentration threshold is
attenuated under conditions of hemophilia A and B. Specif-
ically, the concentration of surface-bound TF required to
surpass the threshold for thrombin production was approxi-
mately two-fold higher for the simulated hemophilias than
for normal hemostatic conditions (0.07 and 1.4 fmol/cm2
for venous and arterial conditions, respectively). Further-
more, the hemophilias were associated with a decrease in
the rate of thrombin generation and a lower FSTG (Fig. S3).
Threshold-type behavior was also observed in relation to
TM surface concentration (Fig. 2, E and F). The minimum
[TM]s required to limit thrombin propagation were 1.4 and
60 fmol/cm2 for [TF]s of 0.03 and 0.8 fmol/cm2 under
venous and arterial shear rates, respectively. As would be
anticipated, the magnitude of flow had a pronounced
effect on the threshold for thrombin production. Assuming
a TF site of 2 mm in length and [TF] and [TM] of 1 andE
F H
G
ty, and TM surface density under simulated arterial flow (500 s1). (A and B)
ar rate of 500 s1. [TF] and [TM] were 1 and 1000 fmol/cm2, respectively.
sity. TF and TM lengths were 2 and 34 mm, respectively. [TM] was fixed at
s of TM surface density. [TF] was fixed at 0.8 fmol/cm2. (G and H) Peak
M lengths were 2 and 34 mm, respectively. [TF] and [TM] were 1 and
tting is defined at FSTG of 10 nM (dotted line).
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pressed at shear rates >750 s1 (Fig. 2, G and H).APC attenuates thrombin production and spatial
propagation over the downstream TM surface
Surface factor concentrations were plotted for the 60-min
simulation time. At the interface between TF and TM
expression (x ¼ 0.2 cm), under conditions in which an acti-
vation threshold was exceeded ([TF] of 0.9 fmol/cm2, [TM]
of 1000 fmol/cm2, shear rate of 500 s1), modulation of Va
and thrombin production by APC occurred within the first
3–5 min, but after an initiation period of 37 min, thrombin
concentration rose rapidly and plateaued (Fig. S4 A). At
points downstream (Fig. 3 A), procoagulant enzyme com-
plexes continue to assemble and thrombin production prop-
agates rapidly in a characteristic sigmoidal time course,
however dampened by the inhibitory TM pathway.
In contrast, below an activation threshold ([TF] of 0.8
fmol/cm2, [TM] of 1000 fmol/cm2, shear rate of 500 s1),
Va decreased in response to increases in APC, restricting
thrombin to very low levels. Va concentrations approached
steady state by ~20 min for the subthreshold case
(Fig. S4 B). Downstream over the TM surface, both the
time to maximum rate of thrombin production and the
magnitude of thrombin generation are attenuated (Fig. 3 B).TF, TM, and shear rate dictate the dimensions of
an effective prothrombotic zone that extends
beyond the initiating site of thrombin generation
These studies emphasize the existence of a spatially defined
zone of thrombin that may extend well beyond the site of TF
expression. This phenomenon holds true whether or not
a system exceeds an activation threshold. EPZ is a conve-
nient measure of the capacity of TM to confine thrombin
generation to the vicinity of the injury site. As shown in
Fig. 4 A, the relationship between a spatially discrete site
of TF expression and EPL is a concave-up nonlinear func-
tion. The influence of the flow regime on the dimensionsA B
Biophysical Journal 101(2) 276–286of the EPZ was investigated at shear rates ranging from
750 to 2000 s1. It might be anticipated that higher flow
rates would promote downstream propagation of thrombin.
However, increasing shear rate decreased the EPZ due to
enhanced removal of activated clotting factors and greater
APC generation attributed to increased transport of
thrombin and PC to TM. Propagation of the EPZ parallel
and perpendicular to the direction of flow was reduced at
higher shear rates (Fig. 4 B). In particular, at the chamber
outlet (x ¼ 3.6 cm), EPH decreased linearly from 15.3%
to 11.3% of the total chamber height, and EPL decreased
nonlinearly from 0.95 to 0.49 cm when the shear rate
increased from 750 to 2000 s1. Increasing TF and TM
surface concentration led to a respective increase or
decrease in the dimensions of the EPZ. Specifically, EPL
increased significantly with TF density (Fig. 4 C), whereas
it decreased in response to TM (Fig. 4 D). EPL was linearly
related to peak APC concentration, R2 ¼ 0.998 (Fig. S5).
It is noteworthy that similar EPZ dimensions may arise
from a wide variety of sizes of TF expression sites, [TF]
and [TM], and shear rate. EPZ contours for decreasing
concentrations of surface TM are shown in Fig. 5. Under
conditions that did not exceed the activation threshold,
EPZ remained near the site of TF expression. For conditions
in which an activation threshold was exceeded, the EPZ
encompassed and extended beyond the entire downstream
region.TM expression within the intervening regions
dictates the suppressive interactions that occur
between sequential TF sites
Multiple TF sites acted cooperatively to promote or
suppress thrombin generation, dependent in part on the
concentration of surface-bound TM within intervening
regions. In Fig. 6, rFSTGs in three regions located between
sequential sites of TF were compared as a function of TM
surface density ranging from 40 to 1000 fmol/cm2. TF
length and concentration were fixed at 200 mm and 9
fmol/cm2, respectively. The TF interval was 1 cm. At lowFIGURE 3 Thrombin concentration at various
points along the surface as a function of time for-
systems that lie (A) above, with [TF] of 0.9 fmol/
cm2 and [TM] of 1000 fmol/cm2, or (B) below,
with [TF] of 0.8 fmol/cm2 and [TM] of 1000
fmol/cm2, a prothrombotic activation threshold
at 500 s1. Note the different scales.
A B
C D
FIGURE 4 Factors influencing EPZ. (A–D)
Relationship of EPL to TF length, wall shear
rate, TF density, and TM density, respectively.
For A–C, TFlength is 2 mm, wall shear rate is
500 s1, [TF] is 1 fmol/cm2, and [TM] is 1000
fmol/cm2 when fixed. In B, EPH is shown as
a percentage of total chamber height. In D, [TF]
is 0.8 fmol/cm2, TFlength is 2 mm, and wall shear
rate is 500 s1.
Thrombin Generation in a Flow Field 281levels of TM, thrombin generated from the first TF region
enhanced thrombin production at downstream TF sites by
driving positive feedback loops of the coagulation cascade.
At intermediate levels of TM expression, thrombin gener-
ated by the upstream site additionally served to activate
PC, thus counteracting thrombin propagation to some
degree. At high densities of TM, the extent of thrombin-
mediated APC generation was great enough to suppress
thrombin production by downstream sites of TF. The degree
of suppression between TF sites was proportional to TM
concentration and was more pronounced between the first
and second regions than between the second and third TF
sites (56% and 8% decreases in rFSTG, respectively, forFIGURE 5 EPZ and its dependence on TM surface concentration (1000,
500, 100, and 80 fmol/cm2), for a wall shear rate of 500 s1, TFlength of
2 mm, and [TF] of 0.8 fmol/cm2. Simulations were run to 60 min. The
EPZ is delineated by a contour line, wherein at any point within the space,
the thrombin concentration was within 95% of the peak level.[TM] of 500 fmol/cm2, and 83% and 28% decreases, respec-
tively for [TM] of 1000 fmol/cm2). Because thrombin regu-
lates its own generation through the production of APC, the
dampened suppressive effects between the second and third
TF sites can be accounted for by the reduced levels of
thrombin generated by the second TF site. Representative
surface plots of thrombin concentration for additive, inter-
mediate, and suppressive interactions are shown in Fig. 6.
The extent to which sequential regions of TF and TM acted
to inhibit or promote thrombin generation was dictated by
the degree to which tandem EPZs overlapped.
The relationship between EPZ and TF interval is further
illustrated in Fig. S6. The intensity of additive prothrom-
botic effects increased as the TF interval decreased, and
conversely, the intensity of suppressive antithrombotic
effects increased as TF interval and TM length increased.DISCUSSION
Computational modeling of blood coagulation
Mathematical models of blood coagulation have been devel-
oped with varying degrees of complexity and for appli-
cations including the study of coagulation phenomena,
pharmacologic and biomaterial development, and simula-
tion of clinical diagnostic values. A review and discussion
of the literature, focusing on those studies that incorporateBiophysical Journal 101(2) 276–286
FIGURE 6 Additive, intermediate, and suppressive interactions between tandem prothrombotic sites. (A) rFSTG as a function of intervening TM
surface density (40–1000 fmol/cm2) under simulated arterial conditions (500 s1) over three sequential sites of TF (TFlength ¼ 200 mm, [TF] ¼
9 fmol/cm2). From left to right, each bar represents rFSTG for the regions downstream of each site of surface-bound TF. (B–D) The EPZ, previously
calculated from a simulation of a single site of TF, is overlaid on the surface plot to illustrate the overlap of EPZ between sequential TF sites. Included
are representations of additive effects at low surface densities of TM (40 fmol/cm2) (B), the net effect of both additive and suppressive interactions
between TF sites at intermediate surface concentrations of TM (100 fmol/cm2) (C), and suppressive interactions between TF sites at high surface
Biophysical Journal 101(2) 276–286
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Thrombin Generation in a Flow Field 283spatial effects, may be found in the Supporting Material. We
have characterized a computational model of coagulation,
which integrates the effects of reaction kinetics, a simple,
yet computationally expandable, flow regime, and uniquely
heterogeneous surface expression. Our model simulated
threshold effects with respect to the length of the TF site,
TF and TM surface densities, and wall shear rate, and repro-
duced the classic time course characterized by initiation and
amplification of thrombin generation. Furthermore, our TF
length threshold was consistent with experimental work
by Shen and colleagues, who measured a TF threshold
size of ~400 mm in a capillary perfusion system under low
shear rates (40 s1) in the absence of TM regulation (23).
It is interesting to note that the threshold TF length in that
study at transport-limited levels of TF and TM was found
to be within the length range of ruptured plaques associated
with acute thrombotic occlusion (14). With respect to TF
density, we computed thresholds of 0.03 and 0.8 fmol/cm2
for wall shear rates of 50 and 500 s1, respectively. Using
patterned microarrays, Okorie et al. determined critical TF
concentrations of 0.6, 1.4, and 1.7 fmol/cm2 for wall shear
rates of 100, 500, and 1000 s1, respectively (24). In
a computational study, Kuharsky and Fogelson predicted
a TF density threshold of ~3 fmol/cm2 at 500 s1 (7). It
has been estimated using ex vivo carotid plaque scraping
that the average phospholipid membrane-associated TF
underlying atherosclerotic plaques is 33 pg TF/cm2 or
1 fmol/cm2 (25). The principle of a TF threshold is signifi-
cant, since it is unlikely that the vasculature is completely
without defect. An understanding of the regulation of blood
coagulation requires consideration not only of antithrom-
botic biochemical pathways but also of coagulation thresh-
olds. As we have demonstrated, these variables may not be
studied in isolation; for example, wall shear rate has
a profound effect on the TF density threshold.
In addition to generating transient concentration profiles,
we have defined a global parameter, FSTG, that reflects three
key qualities of the thrombin response: 1), intensity of the
response; 2), relative onset of amplification; and 3), localiza-
tion of the thrombin foci near to the upstream injury area.
Subthreshold systems are characterized by FSTG <10 nM,
whereas those systems that cause full activation of the coag-
ulation cascade fall along a continuous scale where FSTG is
>10 nM. The choice of a consistent 1-h simulation time
ensured inclusion of early and late phases of coagulation.
Although there is some postprocessing loss of information
due to averaging, it is notable that the results of spatially
homogeneous models are intrinsically averaged.
Perhaps the most intriguing result of this study was the
identification of an EPZ that may be significantly larger
than the dimensions of the spatially discrete site of TFconcentrations of TM (1000 fmol/cm2) (D). Simulations were run to 60 min. H
avoid scaling artifacts. Note the different scale bars.expression in both radial (EPH) and axial (EPL) directions,
with implications for clot growth leading to arterial or
venous thrombosis, as well as systemic procoagulant effects
leading to further hypercoagulability. The geometric param-
eters EPL and EPH are therefore measures of the vital func-
tion of hemostasis to confine thrombus formation to an
injury site. Shen et al. reported that spatial propagation of
thrombin was limited to a 100-mm distance from a discrete
patch of TF under conditions that did not lead to exceeding
a threshold for thrombin propagation (23). A remarkable
increase in the EPZ may occur under conditions that lead
to a reduction in the surface concentration of TM. This
effect is further enhanced in a low-flow regime. These
results are consistent with those reported by Ataullakhanov
et al. for experimental and computational studies in a diffu-
sion-limited system, in which thrombin generation and clot
formation were inhibited by solution-phase TM, with final
clot lengths of 0.2–2 mm under diffusive conditions (8,9).Atherosclerosis and the importance of
interactions between multiple lesions
Despite advances in prevention, patient education, and
pharmaceutical therapies, atherosclerosis remains a signifi-
cant source of morbidity and is estimated to be responsible
for nearly 75% of all cardiovascular-related mortality (26).
Atherosclerosis is a diffuse disease affecting all vessels, and
long-range communication between sites cannot be
excluded, particularly in the presence of flow. Furthermore,
tandem lesions, consisting of more than one ulcerated
plaque or stenosis in series within a single coronary or
peripheral artery, are common occurrences and pose unique
hemodynamic challenges (27,28). It may be concluded
from these computational observations that neither
measurement of lesion morphology alone nor identification
of the isolated rupture risk of a single plaque is sufficient to
determine the likelihood of acute coronary syndromes or
sudden cardiac death. Indeed, it has been suggested that
smaller, nonobstructive plaques could be most dangerous
simply because they by far outnumber the larger, obstruc-
tive plaques (29). Accurate assessment of plaque vulnera-
bility and subsequent management of high-risk plaques or
systems of plaques through pharmaceutical or interven-
tional therapies could greatly diminish morbidity associated
with ischemic cardiac injury and decrease the incidence of
sudden cardiac death.
Exposure of large amounts of TF to the bloodstream from
within the necrotic core of plaque lesions is thought to be
responsible for the hyperthrombotic state of atherosclerotic
vessels (30). Campo et al. measured FVII and TF antigen
levels for 256 patients admitted for acute myocardialowever, thrombin concentration profiles shown here are at t ¼ 18 min to
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dence of death and reinfarction within a median follow-up
period of 397 days (hazard ratio of 2.1 for FVII and 4.1
for TF) (31). The investigators of the AtheroGene study,
which included 1669 patients with coronary artery disease
with a median follow-up of 2.3 years, reported a hazard ratio
of 2.06 for soluble plasma TF levels and cardiovascular
death in individuals with acute coronary syndrome (32).
In a similar way, a 30-year review of the Northwick Park
Heart Study (NPHS-1) observed a significant association
of FVII with fatal coronary heart disease (relative risk 1.58
in men, 1.78 in women); no correlation was found with
nonfatal heart disease (33). Amiodarone is known to decrease
mortality in patients with coronary artery disease and
decreased ejection fraction. Although it is recognized as an
antiarrhythmic agent, amiodarone may mediate this effect
by inhibiting tumor-necrosis-factor-a- and thrombin-
induced TF expression, as observed in cultured human
vascular cells, as well as in a mouse photochemical carotid
injury model (34).
It is interesting that upstream TF regions promote TM and
thrombin-mediated generation of the anticoagulant APC,
which acts to dampen the thrombin response at distal sites.
In a study of 335 patients admitted with ST-elevation
myocardial infarction, decreased APC levels were found
to be a prognostic parameter for high risk of death, with
an adjusted odds ratio of 9.4 for an APC cutoff at 65%
(35). In a retrospective study comparing patients with severe
atherosclerosis and ischemic cardiomyopathy to matched
controls, Laszik et al. (36) determined a 2.4-fold decrease
in TM staining of endothelial cells of the coronary arteries.
In concordance with our findings, it may be inferred that
management strategies that support TM expression and
upregulation should be pursued for patients found to have
more than a few coronary plaques, despite the apparent
subclinical size of individual lesions. The effects of TM
surface concentration may also have implications for early
autologous vein-graft failure due to thrombosis. Immuno-
histochemical staining and Western blot analysis revealed
a transient reduction in TM expression of >95% during
the first 2 weeks after implantation of autologous vein grafts
in a rabbit model (37).
We have predicted that the additive interactions of more
than one subclinical atherosclerotic lesion may result in
a clinically relevant thrombotic response due in part to the
existence of an EPZ that extends beyond the anatomical
dimensions of an injury site. EPZ is governed by the dimen-
sion and concentration of the TF-expressing site, the integ-
rity of the surrounding TM-APC system, and blood flow.
Furthermore, a major determinant of a system’s overall
behavior is the relationship between EPL and the interval
distance between lesions. It is important to note that
suppressive interactions were also observed and were found
to be governed by the surface density of TMwithin the inter-
vening regions.Biophysical Journal 101(2) 276–286Limitations and extensions
The computational model presented here is capable of simu-
lating features of the coagulation cascade, namely the rapid
all-or-none response of thrombin activation, characteristic
initiation and amplification phases, and quantitative values
within an appropriate range of concentrations. Although it
may be suggested that any phenomena may be mathemati-
cally reproduced given 16 diffusion coefficients, 10 inlet
concentrations, and 36 kinetic parameters, it bears emphasis
that the reaction pathways and related kinetic parameters are
largely well defined for the coagulation cascade, and that no
parameter fitting was performed in this model system. Given
a different set of physiologically relevant parameters, the
observed qualitative trends would likely have remained
unchanged.
A number of assumptions were made for reasons of
computational simplicity and feasibility. First, steady, one-
dimensional laminar flow in a two-dimensional rectangular
flow field was assumed. This algebraically defined flow
profile enabled the effect of wall shear rate to be directly
studied but did not reflect the pulsatile flow of the arterial
system or turbulent flow patterns often observed at bifurca-
tion, or branching, points. It should be noted that the FEM
approach allows for the possibility of incorporating more
complex flow geometries and nonsteady flows by the addi-
tion of the Navier-Stokes equation to solve for x- and
y-components of flow velocity, or by coupling to other exist-
ing computational fluid dynamics models. Future work may
model atherosclerotic lesions, which not only represent
areas of increased TF, but are often areas of stenosis and
consequently locally increased wall shear rates. Although
our initial modeling studies would suggest a protective
effect, the decreased shear immediately downstream of the
plaque may decrease the ability of unaffected vasculature
to abrogate the thrombin load.
TF surface presentation was assumed constant over the
60-min simulation period. In other words, the TF stimulus
responsible for initiating the reaction cascade is never
turned off, and its catalytic activity is inhibited only by
TFPI. As suggested by Fogelson et al. (7,11), physical inhi-
bition of surface-bound TF by fibrin and platelet deposition
is an important regulatory mechanism to incorporate into
future works. Related to this, platelet deposition contributes
additional activated phospholipid surfaces not currently
described by our model.SUMMARY
With the advances in computational methods, theoretical
models of coagulation may consider many phenomenolog-
ical aspects efficiently and more completely. We have pre-
sented a FEM of coagulation under flow, with particular
attention to spatial regulation. By eliminating the assump-
tion of spatial homogeneity and describing discrete sites of
Thrombin Generation in a Flow Field 285TF and TM surface reactivity, localization of thrombin
formation by downstream TM was not only demonstrated
but quantified by the definition of an EPZ in two dimen-
sions. Although extension of thrombin generation away
from the wall toward the center of the vascular space
may contribute to vessel occlusion and stasis of flow, pro-
thrombotic effects, which extend downstream beyond the
discrete site of injury to interact with subsequent lesions,
are critical given the systemic and generalized nature of
atherosclerotic disease. The TM-APC pathway is a key
determinant of the local thrombin response, particularly
in the setting of regional systems of multiple TF-laden
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